GLP-1 Signaling in Truncally Vagotomized Subjects

NCT02940184 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Physiology

Interventions

DRUG: Tablet Sitagliptin 100mg (evening before and morning of experiments)
OTHER: Intestinal Fructose administration

Sponsor

University of Copenhagen

Collaborators

[object Object]